ABCB1 |
P08183
|
ATP binding cassette subfamily B member 1
|
Transporter
|
1.3E-05 |
0.344 |
0.885 |
ABL1 |
P00519
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
Kinase
|
1.00 |
0.432 |
0.923 |
ACE |
P12821
|
angiotensin I converting enzyme
|
Enzyme
|
1.0E-37 |
0.328 |
0.923 |
AK6 |
Q9Y3D8
|
adenylate kinase 6
|
|
|
0.678 |
0.538 |
AKT1 |
P31749
|
AKT serine/threonine kinase 1
|
Kinase
|
0.98 |
0.311 |
0.962 |
ALK |
Q9UM73
|
ALK receptor tyrosine kinase
|
Kinase
|
3.2E-06 |
0.396 |
0.846 |
ALL1 |
|
Leukemia, acute lymphocytic, susceptibility to, 1
|
|
|
0.636 |
0.269 |
ASXL1 |
Q8IXJ9
|
ASXL transcriptional regulator 1
|
|
1.3E-14 |
0.482 |
0.808 |
ATN1 |
P54259
|
atrophin 1
|
|
1.00 |
0.409 |
0.885 |
BCR |
P11274
|
BCR activator of RhoGEF and GTPase
|
Enzyme modulator
|
0.99 |
0.431 |
0.885 |
BCRP3 |
|
BCR pseudogene 3
|
|
|
0.705 |
0.269 |
CALCA |
P01258 P06881
|
calcitonin related polypeptide alpha
|
Signaling
|
1.6E-02 |
0.416 |
0.923 |
CALR |
P27797
|
calreticulin
|
Calcium-binding protein
|
0.89 |
0.413 |
0.923 |
CBL |
P22681
|
Cbl proto-oncogene
|
Enzyme
|
6.1E-04 |
0.527 |
0.769 |
CCDC28A |
Q8IWP9
|
coiled-coil domain containing 28A
|
Receptor
|
3.6E-10 |
0.780 |
0.154 |
CCR7 |
P32248
|
C-C motif chemokine receptor 7
|
G-protein coupled receptor
|
5.8E-02 |
0.443 |
0.769 |
CD34 |
P28906
|
CD34 molecule
|
|
5.0E-06 |
0.368 |
0.808 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
CDKN2B |
P42772
|
cyclin dependent kinase inhibitor 2B
|
|
7.3E-03 |
0.417 |
0.769 |
COL11A2 |
P13942
|
collagen type XI alpha 2 chain
|
|
0.70 |
0.435 |
0.846 |
CREBBP |
Q92793
|
CREB binding protein
|
|
1.00 |
0.428 |
0.808 |
CRYZ |
Q08257
|
crystallin zeta
|
|
5.7E-23 |
0.524 |
0.731 |
CSF1R |
P07333
|
colony stimulating factor 1 receptor
|
Kinase
|
0.13 |
0.448 |
0.808 |
CSF2 |
P04141
|
colony stimulating factor 2
|
Signaling
|
0.83 |
0.330 |
0.962 |
CSF3 |
P09919
|
colony stimulating factor 3
|
|
0.38 |
0.377 |
0.885 |